XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2021
Stockholders' Equity Attributable to Parent [Abstract]  
Components of Accumulated Other Comprehensive Income (Loss)
The components of the change in accumulated other comprehensive loss, net were as follows:
Defined Benefit PlansDerivativesAccumulated Other Comprehensive Loss, Net
(In thousands)
Balance as of December 30, 2020$(978)$(59,427)$(60,405)
Amortization of net loss (1)
40 — 40 
Changes in the fair value of cash flow derivatives— 2,978 2,978 
Reclassification of cash flow derivatives to interest expense, net (2)
— 995 995 
Amortization of unrealized losses related to dedesignated derivatives to interest expense, net (3)
— 121 121 
Income tax expense related to items of other comprehensive income(10)(1,049)(1,059)
Balance as of March 31, 2021$(948)$(56,382)$(57,330)

(1)    Amount related to our defined benefit plans that was reclassified from accumulated other comprehensive loss, net and included as a component of pension expense within general and administrative expenses in our Condensed Consolidated Statements of Operations during the quarter ended March 31, 2021.
(2)    Amounts reclassified from accumulated other comprehensive loss, net into interest expense, net in our Condensed Consolidated Statements of Operations represent payments either received from or made to the counterparty for the interest rate swaps. See Note 7 for additional details.
(3)    The losses related to the 2018 Swaps will continue to be included in accumulated other comprehensive loss, net and will be amortized as a component of interest expense, net in our Consolidated Statements of Operations over the remaining term of the 2018 Swaps. For the quarter ended March 31, 2021, we amortized approximately $0.1 million of losses to interest expense, net related to the 2018 Swaps. We expect to amortize less than $0.1 million from accumulated other comprehensive loss related to our interest rate swaps during the next 12 months. See Note 7 for additional details.